Clinical Prognosis of High sensitivity C Reactive Protein Guiding Interventional Therapy for Coronary Heart Disease
Fan Jun
Zhang Hong
Zhao Jing
Zhao Xingshan
Hao Zhihua
Abstract：Objective To investigate the clinical prognosis values of high sensitivity C reactive protein(hs CRP)guiding interven-tional therapy for the coronary heart disease(CHD)patients.Methods From May 2011 to May 2015,130 patients with CHD in our hospital were selected for treatment,al patients were given intervention. The cardiac function,serum hs CRP changes were ob-served before and after the intervention.According to preoperative serum CRP levels,patients were divided into group A(CRP≥3 mg/L) and group B(CRP<3 mg/L).Results Al patients were involved in successful,left ventricular ejection fraction(LVEF)values in post-operative 3 months was significantly higher than that in postoperative 1 month(P<0.05).The levels of serum hs CRP in postopera-tive 7 days was significantly higher than that in postoperative 3 days and before operation(P<0.05).There were 14 patients of major adverse cardiovascular events(MACE)occurred within fol owed up 3 months,the incidence were 10.8%.The incidence of MACE in group A were significantly higher than that in group B(P<0.05).LVEF in postoperative 1 month and 3 months were lower in group A than that in group B(P<0.05).Conclusion The interventional therapy for CHD can improve heart function and has higher success rates,but it can contribute to elevate hs CRP levels in the short term.The preoperative hs CRP levels can predict MACE after inter-vention .
Keywords：coronary heart diseasehigh sensitivity C reactive proteininterventional therapymajor adverse cardiovascular events
Publication Date：2016-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 395-398 )